Retraction: Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity

PDF  |  How to cite

Oncotarget. 2022; 13:1322-1322. https://doi.org/10.18632/oncotarget.28325

Metrics: PDF 425 views  |   ?  

Yueqiang Jiang1,*, Yanling Ma2,*, RuiChao Li1 and JianHai Sun2

1Department of Gerontology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China
2Department of Oncology, the Third People’s Hospital, Wuhan, Hubei Province, China
*Co-first author

Published: December 17, 2022

Copyright: © 2022 Jiang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: During its investigation, Oncotarget requested the original data for this paper from the authors. The authors state: "After investigation, we determined that some original data were lost and we cannot repeat the results, making data interpretation difficult and conclusion unreliable." All authors have therefore agreed to the retraction of this paper from Oncotarget.

Original article: Oncotarget. 2018; 9:11989–11998. DOI: https://doi.org/10.18632/oncotarget.22857

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28325